| __timestamp | Celldex Therapeutics, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 94231000 |
| Thursday, January 1, 2015 | 100171000 | 146394000 |
| Friday, January 1, 2016 | 102726000 | 188272000 |
| Sunday, January 1, 2017 | 96171000 | 166707000 |
| Monday, January 1, 2018 | 66449000 | 401843000 |
| Tuesday, January 1, 2019 | 42672000 | 560909000 |
| Wednesday, January 1, 2020 | 42534000 | 722343000 |
| Friday, January 1, 2021 | 53311000 | 771182000 |
| Saturday, January 1, 2022 | 82258000 | 877090000 |
| Sunday, January 1, 2023 | 118011000 | 877387000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Sarepta Therapeutics, Inc. and Celldex Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Sarepta's R&D expenses surged by over 830%, peaking in 2023 with a staggering 877 million dollars. In contrast, Celldex's R&D spending showed a more modest increase of approximately 13% over the same period, reaching 118 million dollars in 2023. This stark difference highlights Sarepta's aggressive pursuit of innovation, while Celldex maintains a more conservative approach. As the biotech industry continues to evolve, these spending patterns may influence each company's ability to bring groundbreaking therapies to market, ultimately impacting their competitive standing and market share.
Bristol-Myers Squibb Company vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
United Therapeutics Corporation or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Genmab A/S vs Celldex Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Sarepta Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
TG Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Mesoblast Limited and Celldex Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Wave Life Sciences Ltd. and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Celldex Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.